Mukai Tokunori, Hiromatsu Yuji, Ichimura Michiko, Fukutani Tomoka, Kaku Hiroo, Miyake Ikuyo, Shoji Shingo, Koda Yoshiro, Bednarczuk Tomasz
Department of Endocrinology and Metabolism, Kurume University School of Medicine, Fukuoka, Japan.
Thyroid. 2006 Mar;16(3):243-8. doi: 10.1089/thy.2006.16.243.
To investigate whether polymorphisms of interleukin (IL)-18 gene confer susceptibility to Graves' disease (GD) and Graves' ophthalmopathy (GO).
We performed a case control study on polymorphisms of IL-18 gene in Japanese patients with GD (n = 435), and healthy control subjects without antithyroid autoantibodies or family history of autoimmune disorders (n = 255). The C-4675G, C-607A, and G-137C polymorphisms in the promoter region and A105C (exon 5) polymorphism were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) using restriction enzymes, sequence-specific PCR, and PCR-direct sequencing methods.
None of the polymorphisms in the IL-18 gene were associated with development of Graves' disease. The CC genotype and C allele frequencies of IL-18 gene G-137C polymorphism tended to be greater in patients with ophthalmopathy than in patients without evident ophthalmopathy. However, the differences were not statistically significant. Although there were three major haplotypes, none of the haplotypes were statistically associated with susceptibility to GD or ophthalmopathy.
These results suggest that IL-18 gene polymorphisms are not major genetic factors for susceptibility to GD in a Japanese population. Further studies with adequate sized data set in the subset analyses for GO are needed.
研究白细胞介素(IL)-18基因多态性是否与格雷夫斯病(GD)及格雷夫斯眼病(GO)易感性相关。
我们对日本GD患者(n = 435)及无抗甲状腺自身抗体或自身免疫性疾病家族史的健康对照者(n = 255)进行了IL-18基因多态性的病例对照研究。采用限制性内切酶、序列特异性PCR及PCR直接测序法,通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)检测启动子区域的C-4675G、C-607A和G-137C多态性以及外显子5的A105C多态性。
IL-18基因的多态性均与格雷夫斯病的发生无关。IL-18基因G-137C多态性的CC基因型和C等位基因频率在有眼病的患者中比无明显眼病的患者中倾向于更高。然而,差异无统计学意义。虽然有三种主要单倍型,但没有一种单倍型与GD或眼病的易感性有统计学关联。
这些结果表明,在日本人群中,IL-18基因多态性不是GD易感性的主要遗传因素。需要在GO的亚组分析中进行有足够样本量的进一步研究。